Bioymifi
CAS: 1420071-30-2
Ref. 3D-VGC07130
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Bioymifi is a cyclic peptide that belongs to the group of growth factors. It activates epidermal growth factor (EGF) and other growth factors, which are involved in cell proliferation and differentiation. Bioymifi has been shown to be effective at treating pancreatitis by inducing apoptosis in tumor cells. Bioymifi also is known to induce apoptosis by activating caspase-3 and other molecules involved in the apoptosis pathway. Bioymifi has been shown to have anti-cancer properties, as well as cardioprotective effects, which may be due to its ability to induce mitochondrial membrane depolarization and histological changes in cardiac tissue.
Chemical properties
Technical inquiry about: 3D-VGC07130 Bioymifi
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
